Feasibility of the ACL (albumin, C-reactive protein and lactate dehydrogenase) model as a novel prognostic tool in patients with metastatic renal cell carcinoma previously receiving first-line targeted therapy

Autor: Tamura, Keita, Matsushita, Yuto, Watanabe, Hiromitsu, Motoyama, Daisuke, Ito, Toshiki, Sugiyama, Takayuki, Otsuka, Atsushi, Miyake, Hideaki
Zdroj: In Urologic Oncology: Seminars and Original Investigations January 2020 38(1):6-6
Databáze: ScienceDirect